Effect of Hydrocortisone on Mortality or Respiratory Support Among Critically Ill COVID-19 Patients

This randomized clinical trial compares the effect of low-dose hydrocortisone vs placebo on treatment failure (death or persistent respiratory support dependency) at 21 days in critically ill patients with COVID-19 and acute respiratory failure in France.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research